Can the detection of misery perfusion in chronic cerebrovascular disease be based on reductions in baseline CBF and vasoreactivity?

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 34, Issue 1, 2007, Pages 121-129

  Okazawa, Hidehiko ^a   Tsuchida, Tatsuro ^a   Kobayashi, Masato ^a   Arai, Yoshikazu ^a   Pagani, Marco ^a   Isozaki, Makoto ^a   Yonekura, Yoshiharu ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

Acetazolamide; Cerebral blood flow; Cerebral vasoreactivity; Chronic cerebrovascular disease; Misery perfusion

Indexed keywords

ACETAZOLAMIDE; OXYGEN 15; WATER;

ADULT; AGED; ARTICLE; BLOOD VESSEL REACTIVITY; BRAIN BLOOD FLOW; BRAIN METABOLISM; BRAIN PERFUSION; CEREBROVASCULAR DISEASE; CHRONIC DISEASE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY; POSITRON EMISSION TOMOGRAPHY;

ACETAZOLAMIDE; ADULT; AGED; ANTICONVULSANTS; CEREBROVASCULAR CIRCULATION; CEREBROVASCULAR DISORDERS; HUMANS; MALE; MIDDLE AGED; OXYGEN; VASOMOTOR SYSTEM;

EID: 33845369451     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-006-0192-5     Document Type: Article

References (31)

1. Yamauchi H, Fukuyama H, Nagahama Y, Nabatame H, Nakamura K, Yamamoto Y, et al. Evidence of misery perfusion and risk for recurrent stroke in major cerebral arterial occlusive diseases from PET. J Neurol Neurosurg Psychiatry 1996;61:18-25
2. Grubb RL Jr, Derdeyn CP, Fritsch SM, Carpenter DA, Yundt KD, Videen TO, et al. Importance of hemodynamic factors in the prognosis of symptomatic carotid occlusion. JAMA 1998;280:1055-60
3. Yamauchi H, Fukuyama H, Nagahama Y, Nabatame H, Ueno M, Nishizawa S, et al. Significance of increased oxygen extraction fraction in five-year prognosis of major cerebral arterial occlusive diseases. J Nucl Med 1999;40:1992-8
4. Kuroda S, Houkin K, Kamiyama H, Mitsumori K, Iwasaki Y, Abe H. Long-term prognosis of medically treated patients with internal carotid or middle cerebral artery occlusion: can acetazolamide test predict it? Stroke 2001;32:2110-6
5. Ogasawara K, Ogawa A, Terasaki K, Shimizu H, Tominaga T, Yoshimoto T. Use of cerebrovascular reactivity in patients with symptomatic major cerebral artery occlusion to predict 5-year outcome: comparison of xenon-133 and iodine-123-IMP single-photon emission computed tomography. J Cereb Blood Flow Metab 2002;22:1142-8
6. Vorstrup S, Brun B, Lassen NA. Evaluation of the cerebral vasodilatory capacity by the acetazolamide test before EC-IC bypass surgery in patients with occlusion of the internal carotid artery. Stroke 1986;17:1291-8
7. Derdeyn CP, Grubb RL Jr, Powers WJ. Cerebral hemodynamic impairment: methods of measurement and association with stroke risk. Neurology 1999;53:251-9
8. 15O positron emission tomography. Stroke 1981;12:454-9
9. Powers WJ, Press GA, Grubb RL Jr, Gado M, Raichle ME. The effect of hemodynamically significant carotid artery disease on the hemodynamic status of the cerebral circulation. Ann Intern Med 1987;106:27-34
10. Powers WJ. Cerebral hemodynamics in ischaemic cerebrovascular disease. Ann Neurol 1991;29:231-40
11. Okazawa H, Yamauchi H, Toyoda H, Sugimoto K, Fujibayashi Y, Yonekura Y. Relationship between vasodilatation and cerebral blood flow increase in impaired hemodynamics: a PET study with the acetazolamide test in cerebrovascular disease. J Nucl Med 2003;44:1875-83
12. Yamauchi H, Okazawa H, Kishibe Y, Sugimoto K, Takahashi M. Oxygen extraction fraction and acetazolamide reactivity in symptomatic carotid artery disease. J Neurol Neurosurg Psychiatry 2004;75:33-7
13. Nemoto EM, Yonas H, Kuwabara H, Pindzola RR, Sashin D, Meltzer CC, et al. Identification of hemodynamic compromise by cerebrovascular reserve and oxygen extraction fraction in occlusive vascular disease. J Cereb Blood Flow Metab 2004;24:1081-9
14. Norrving B, Nilsson B, Risberg J. rCBF in patients with carotid occlusion. Resting and hypercapnic flow related to collateral pattern. Stroke 1982;13:155-62
15. Yonas H, Smith HA, Durham SR, Pentheny SL, Johnson DW. Increased stroke risk predicted by compromised cerebral blood flow reactivity. J Neurosurg 1993;79:483-9
16. Derdeyn CP, Videen TO, Simmons NR, Yundt KD, Fritsch SM, Grubb RL, et al. Count-based PET method for predicting ischaemic stroke in patients with symptomatic carotid arterial occlusion. Radiology 1999;212:499-06
17. Grubb RL Jr, Powers WJ, Derdeyn CP, Adams HP Jr, Clarke WR. The carotid occlusion surgery study. Neurosurg Focus 2003;14:Article 9:1-7
18. DeGrado TR, Turkington TG, Williams JJ, Stearns CW, Hoffman JM, Coleman RE. Performance characteristics of a whole-body PET scanner. J Nucl Med 1994;35:1398-06
19. 15O]water clearance in humans determined by PET: I. Theory and normal values. J Cereb Blood Flow Metab 1996;16:765-80
20. Okazawa H, Yamauchi H, Sugumoto K, Toyoda H, Kishibe Y, Takahashi M. Effects of acetazolamide on cerebral blood flow, blood volume and oxygen metabolism: a PET study with healthy volunteers. J Cereb Blood Flow Metab 2001;21:1472-9
21. Yamamoto S, Tarutani K, Suga M, Minato K, Watabe H, Iida H. Development of a phoswich detector for a continuous blood-sampling system. IEEE Trans Nucl Sci 2001;48:1408-11
22. Okazawa H, Kishibe Y, Sugumoto K, Takahashi M, Yamauchi H. Delay and dispersion correction for a new coincidential radioactivity detector, Pico-Count, in quantitative PET studies. In: Senda M, Kimura Y, Herscovitch P, eds. Brain imaging using PET. San Diego: Academic Press; 2002; p. 15-21
23. 15O autoradiographic method and dynamic PET. J Nucl Med 1989;30:1069-78
24. 15O and positron emission tomography: theory, procedure, and normal values. J Comput Assist Tomogr 1980;4:727-36
25. Lammertsma AA, Wise RJ, Heather JD, Gibbs JM, Leenders KL, Frackowiak RS, et al. Correction for the presence of intravascular oxygen-15 in the steady-state technique for measuring regional oxygen extraction ratio in the brain: 2. Results in normal subjects and brain tumor and stroke patients. J Cereb Blood Flow Metab 1983;3:425-31
26. Nemoto EM, Yonas H, Chang Y. Stages and thresholds of hemodynamic failure. Stroke 2003;34:2-3
27. Kusunoki M, Kimura K, Nakamura M, Isaka Y, Yoneda S, Abe H. Effects of hematocrit variations on cerebral blood flow and oxygen transport in ischemic cerebrovascular disease. J Cereb Blood Flow Metab 1981;1:413-7
28. Román GC, Erkinjuntti T, Wallin A, Pantoni L, Chui HC. Subcortical ischaemic vascular dementia. Lancet Neurol 2002;1:426-36
29. Vernieri F, Pasqualetti P, Matteis M, Passarelli F, Troisi E, Rossini PM, et al. Effect of collateral blood flow and cerebral vasomotor reactivity on the outcome of carotid artery occlusion. Stroke 2001;32:1552-8
30. 0) for the evaluation of hemodynamic changes in cerebrovascular disease. In: Iida H, Shah NJ, Hayashi T, Watabe H, eds. ICS 1265 Quantitation in biomedical imaging with PET and MRI. Amsterdam: Elsevier; 2004; p. 218-27
31. Swenson ER. Carbonic anhydrase inhibitors and ventilation: a complex interplay of stimulation and suppression. Eur Respir J 1998;12:1242-7